NCT03763448

Brief Summary

This study aims to compare the postoperative clinical outcomes of Infrapatellar Fat Pad (IPFP) preservation versus resection after total knee arthroplasty (TKA) in patients with knee osteoarthritis. Participants will be identified as normal IPFP or abnormal IPFP based on MRI findings before randomization. The primary outcome is the change from baseline to 12 months in the mean score on five Knee Injury and Osteoarthritis Outcome Score (KOOS) subscales (KOOS5), covering pain, symptoms, activities of daily life, sport \& recreation, knee-related quality of life, with scores ranging from 0 (worst) to 100 (best). The secondary endpoints will be included: KOOS subscales, Knee Society Score (KSS), 100 mm Visual Analogue Scale (VAS) Pain, timed up-and-go test, depression, patellar tendon shortening, 100 mm VAS self-reported efficacy of reduced pain and increased quality of life. Adverse events will be recorded. Primary and secondary outcomes will be evaluated or reported blindly at baseline and at postoperative 3 months, 6 months, and 1 year. Intention-to-treat analyses will be used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
377

participants targeted

Target at P75+ for not_applicable knee-osteoarthritis

Timeline
Completed

Started Dec 2018

Longer than P75 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 4, 2018

Completed
13 days until next milestone

Study Start

First participant enrolled

December 17, 2018

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 13, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 13, 2024

Completed
Last Updated

December 5, 2025

Status Verified

November 1, 2025

Enrollment Period

5.4 years

First QC Date

October 19, 2018

Last Update Submit

November 27, 2025

Conditions

Keywords

Infrapatellar Fat PadKnee OsteoarthritisTotal Knee ArthroplastyRandomized Clinical Trial

Outcome Measures

Primary Outcomes (1)

  • The mean score on five Knee Injury and Osteoarthritis Outcome Score(KOOS) subscales

    The primary outcome was the change from baseline to 12 months in the mean score on five Knee Injury and Osteoarthritis Outcome Score (KOOS) subscales, covering pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life (KOOS5), with scores ranging from 0 (worst) to 100 (best). The KOOS, a valid, reliable and responsive self-reported questionnaire applied to evaluate the short and long-term patient-relevant outcomes following TKA, consists of five subscales with a total of 42 items: pain (9 items), symptoms (7 items), function in ADL (17 items), sport and recreation function (5 items) and knee-related quality of life (4 items).

    From pre-operation to 12 months after operation

Secondary Outcomes (6)

  • Five individual subscales of Knee Injury and Osteoarthritis Outcome Score (KOOS)

    From pre-operation to 12 months after operation

  • Knee Society Score(KSS)

    From pre-operation to 12 months after operation

  • Self-reported efficacy of reduced pain and increased quality of life

    From pre-operation to 12 months after operation

  • Insall - Salvati Ratio (ISR)

    From pre-operation to 12 months after operation

  • Timed Up and Go test

    From pre-operation to 12 months after operation

  • +1 more secondary outcomes

Study Arms (2)

Infrapatellar Fat Pad Preservation

EXPERIMENTAL

The IPFP retention of more than 80% in actual operation shall be regarded as IPFP retention.

Procedure: Infrapatellar Fat Pad preservation

Infrapatellar Fat Pad Resection

ACTIVE COMPARATOR

In the clinical practice, more than 80% of IPFP volume is commonly resected by surgeons during total knee arthroplasty. The investigators hereby define resection of more than 80% IPFP volume as IPFP excision.

Procedure: Infrapatellar Fat Pad resection

Interventions

In the IPFP preservation group, IPFP (more than 80%) will be preserved by retracting out of the operative field.

Also known as: Infrapatellar fat pad retention
Infrapatellar Fat Pad Preservation

In the IPFP resection group, more than 80% IPFP will be resected during the total knee arthroplasty.

Infrapatellar Fat Pad Resection

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants diagnosed with knee osteoarthritis by X-ray plain film (Kellgren-Lawrence score of ≥ 2)
  • The need for TKA was confirmed after evaluation by the orthopedic surgeon
  • One week before surgery, knee pain 100mm pain visual analogue scale score was greater than 20mm
  • Understanding of the study requirements and willing to participate in this study

You may not qualify if:

  • Rheumatoid arthritis,psoriatic arthritis,lupus,malignant tumor
  • Requiring contralateral TKA within one year
  • The visual analogue score of 100mm of knee pain before operation was less than 20mm
  • Having a possible or planned pregnancy
  • With poor compliance
  • Suffering from somatic disease, psychiatric or cognitive disorders, neurological disorders that will compromise the safety, compliance, consent, participation, follow-up and the interpretation of the results
  • Severe knee valgus
  • Contraindications with TKA or MRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhujiang Hospital

Guangzhou, Guangdong, 510285, China

Location

Related Publications (2)

  • Han W, Cao P, Cen H, Li B, Chen M, Li Y, Yang C, Lu M, Zhang H, Ke Y, Zhu Z, Liu X, Gao P, Zhou X, Liu Y, Dou Z, Liu Y, Zhang M, Lin J, Zha Z, Yin Z, Tian J, Lin L, Shang X, Hunter DJ, Liu J, Lei G, Ding C. Infrapatellar Fat Pad Preservation versus Resection in Total Knee Arthroplasty. NEJM Evid. 2026 Apr;5(4):EVIDoa2500135. doi: 10.1056/EVIDoa2500135. Epub 2026 Mar 24.

  • Zhu Z, Han W, Lu M, Lin J, Yin Z, Shang X, Weng X, Zha Z, Tian J, Lei G, Hunter DJ, Ding C. Effects of infrapatellar fat pad preservation versus resection on clinical outcomes after total knee arthroplasty in patients with knee osteoarthritis (IPAKA): study protocol for a multicentre, randomised, controlled clinical trial. BMJ Open. 2020 Oct 23;10(10):e043088. doi: 10.1136/bmjopen-2020-043088.

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Changhai Ding, MD

    Clinical Research Center of Zhujiang Hospital,Southern Medical University

    PRINCIPAL INVESTIGATOR
  • Jianhao Lin, MD

    Peking University People's Hospital

    PRINCIPAL INVESTIGATOR
  • Xisheng Weng, MD

    Peking Union Medical College Hospital

    PRINCIPAL INVESTIGATOR
  • Guanghua Lei, MD

    Xiangya Hospital of Central South University

    PRINCIPAL INVESTIGATOR
  • Zongsheng Yin, MD

    The First Affiliated Hospital of Anhui Medical University

    PRINCIPAL INVESTIGATOR
  • Zhengang Zha, MD

    First Affiliated Hospital of Jinan University

    PRINCIPAL INVESTIGATOR
  • Jing Tian, MD

    Zhujiang Hospital

    PRINCIPAL INVESTIGATOR
  • Xifu Shang, MD

    Anhui Provincial Hospital

    PRINCIPAL INVESTIGATOR
  • Yujin Tang, MD

    Youjiang Medical College for Nationalities

    PRINCIPAL INVESTIGATOR
  • Jun Liu, MD

    Tianjin Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
participants, outcome assessors, data analysts and chief investigators are masked during the study procedure.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director,Clinical Research Center

Study Record Dates

First Submitted

October 19, 2018

First Posted

December 4, 2018

Study Start

December 17, 2018

Primary Completion

May 13, 2024

Study Completion

May 13, 2024

Last Updated

December 5, 2025

Record last verified: 2025-11

Locations